JP2007504825A5 - - Google Patents

Download PDF

Info

Publication number
JP2007504825A5
JP2007504825A5 JP2006526255A JP2006526255A JP2007504825A5 JP 2007504825 A5 JP2007504825 A5 JP 2007504825A5 JP 2006526255 A JP2006526255 A JP 2006526255A JP 2006526255 A JP2006526255 A JP 2006526255A JP 2007504825 A5 JP2007504825 A5 JP 2007504825A5
Authority
JP
Japan
Prior art keywords
seq
nucleic acid
isolated
isolated peptide
biological sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006526255A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007504825A (ja
Filing date
Publication date
Priority claimed from US10/659,782 external-priority patent/US7176292B2/en
Application filed filed Critical
Publication of JP2007504825A publication Critical patent/JP2007504825A/ja
Publication of JP2007504825A5 publication Critical patent/JP2007504825A5/ja
Pending legal-status Critical Current

Links

JP2006526255A 2003-09-11 2004-09-09 肥満および/または糖尿病を診断、モニタリング、および治療するための組成物、試薬、およびキット、ならびにその方法 Pending JP2007504825A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/659,782 US7176292B2 (en) 2003-09-11 2003-09-11 Ghrelin variant protein
PCT/US2004/029230 WO2005026392A2 (en) 2003-09-11 2004-09-09 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010268513A Division JP5314658B2 (ja) 2003-09-11 2010-12-01 肥満および/または糖尿病を診断、モニタリング、および治療するための組成物、試薬、およびキット、ならびにその方法

Publications (2)

Publication Number Publication Date
JP2007504825A JP2007504825A (ja) 2007-03-08
JP2007504825A5 true JP2007504825A5 (https=) 2007-10-11

Family

ID=34273528

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006526255A Pending JP2007504825A (ja) 2003-09-11 2004-09-09 肥満および/または糖尿病を診断、モニタリング、および治療するための組成物、試薬、およびキット、ならびにその方法
JP2010268513A Expired - Fee Related JP5314658B2 (ja) 2003-09-11 2010-12-01 肥満および/または糖尿病を診断、モニタリング、および治療するための組成物、試薬、およびキット、ならびにその方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010268513A Expired - Fee Related JP5314658B2 (ja) 2003-09-11 2010-12-01 肥満および/または糖尿病を診断、モニタリング、および治療するための組成物、試薬、およびキット、ならびにその方法

Country Status (14)

Country Link
US (2) US7176292B2 (https=)
EP (1) EP1664346B1 (https=)
JP (2) JP2007504825A (https=)
KR (1) KR101081040B1 (https=)
CN (1) CN101023184A (https=)
AT (1) ATE480641T1 (https=)
AU (2) AU2004273053B2 (https=)
BR (1) BRPI0414365A (https=)
CA (1) CA2538514C (https=)
DE (1) DE602004029061D1 (https=)
IL (2) IL174195A (https=)
NZ (1) NZ546488A (https=)
RU (1) RU2420583C2 (https=)
WO (1) WO2005026392A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512971B2 (en) * 2002-12-10 2013-08-20 Echelon Biosciences, Inc. Compounds and methods of use thereof for assaying lysophospholipase D activity
US20050208658A1 (en) * 2003-11-21 2005-09-22 The University Of Maryland RNA interference mediated inhibition of 11beta hydroxysteriod dehydrogenase-1 (11beta HSD-1) gene expression
EP1747264B1 (de) 2004-05-21 2012-09-12 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Multizelluläre gewebe- und organkultursysteme
WO2005119525A1 (en) * 2004-06-04 2005-12-15 Pfizer Products Inc. 11βHSD1 CRYSTAL STRUCTURES FOR STRUCTURE BASED DRUG DESIGN
WO2007055996A2 (en) * 2005-11-03 2007-05-18 Liat Mintz Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance
NZ571183A (en) * 2006-03-13 2010-09-30 Liat Mintz Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation
US7763707B2 (en) * 2006-03-13 2010-07-27 Liat Mintz Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation
WO2007126792A2 (en) * 2006-03-28 2007-11-08 Liat Mintz Use of ghrelin splice variant for treating high cholesterol levels or high plasma glucose levels and releated diseases
WO2009048903A1 (en) * 2007-10-08 2009-04-16 Bristol-Myers Squibb Company 11 beta hydroxysteroid dehydrogenase type 1
JP2011516038A (ja) * 2008-03-12 2011-05-26 オタゴ イノベーション リミテッド バイオマーカー
ES2372337B1 (es) * 2010-06-10 2013-01-18 Servicio Andaluz De Salud Variante de la ghrelina y sus usos.
WO2013113916A2 (en) * 2012-02-03 2013-08-08 Zealand Pharma A/S Ghrelin analogues
CN102721819B (zh) * 2012-06-28 2014-08-13 广州瑞博奥生物科技有限公司 一种脂联素的竞争抑制性酶联免疫检测试剂盒及方法
US20190316204A1 (en) * 2015-07-24 2019-10-17 Korea University Research And Business Foundation Biomarker for determining aging, determining obesity, and diagnosing cancer and diagnosing kit using same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291653B1 (en) * 1997-03-24 2001-09-18 Zymogenetics, Inc. Antibodies to motilin homologs
US20040023874A1 (en) * 2002-03-15 2004-02-05 Burgess Catherine E. Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US6967237B2 (en) 2000-05-30 2005-11-22 Merck & Co., Inc. Ghrelin analogs
DK1426764T3 (da) * 2001-08-17 2011-06-27 Fujirebio Kk Fremgangsmåde til diagnosticering eller monitorering af fejl i sukkermetabolisme
EP1458758A2 (en) * 2001-12-21 2004-09-22 Maxygen Aps Adiponectin fragments and conjugates
AU2002364586A1 (en) * 2001-12-21 2003-07-30 Delta Biotechnology Limited Albumin fusion proteins
WO2003059934A2 (en) * 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin fusion proteins
CA2473781A1 (en) * 2002-01-18 2003-07-31 Protemix Corporation Limited Glycoisoforms of adiponectin and uses thereof
JPWO2003063894A1 (ja) * 2002-01-31 2005-05-26 独立行政法人科学技術振興機構 インスリン抵抗性改善剤
NZ571183A (en) * 2006-03-13 2010-09-30 Liat Mintz Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation

Similar Documents

Publication Publication Date Title
JP2007504825A5 (https=)
JP2012503985A5 (https=)
Becker et al. Transcriptional profiling in human epilepsy: expression array and single cell real-time qRT-PCR analysis reveal distinct cellular gene regulation
JP6269746B2 (ja) βグロビン遺伝子の変異を検出するためのマイクロアレイ及びその検出方法
JP2009519001A5 (https=)
JP2007506426A5 (https=)
WO2003080640B1 (en) Lymphatic and blood endothelial cell genes
JP2014533949A5 (https=)
JP2004528810A5 (https=)
JP2011101652A (ja) 核酸分子の検出方法
JP4490988B2 (ja) 血清アミロイドa1(saa1)の遺伝子型を検出するための核酸プライマーセット、キット、及び該プライマーセットを用いた検出方法
RU2006111720A (ru) Композиции, реагенты, наборы и способы для диагностики, мониторинга и лечения ожирения и/или диабета
JP2008512984A5 (https=)
KR101936246B1 (ko) 혈관경직의 예후 또는 위험도를 평가하는 방법 및 키트
JP6788256B2 (ja) 冠動脈イベント予測のための方法及び試薬
KR101360408B1 (ko) 좌심실비대와 연관된 단일염기다형성 및 그의 용도
KR101168052B1 (ko) 인간 당뇨병 진단용 키트 및 이의 이용
Oudejans et al. Susceptibility allele-specific loss of miR-1324-mediated silencing of the INO80B chromatin-assembly complex gene in pre-eclampsia
EP2087138B1 (en) Microarray for the detection of an angiostatic tumor stage of colorectal carcinoma
WO2009079733A1 (en) Determination of variants produced upon replication or transcription of nucleic acid sequences
JP2005510247A (ja) 翻訳制御された遺伝子発現の分析方法
KR101791246B1 (ko) 크론병의 임상적 특성의 예측 방법
JP2022515838A5 (https=)
KR102409336B1 (ko) 면역글로불린 a 신병증 및 혈관염 진단용 snp 마커 및 이를 이용한 진단 방법
US20250197918A1 (en) Preparation and use of blocked substrates